Nucleus Software has shown mixed financial performance. While sales growth has been robust, profit growth has been inconsistent. Compounded Sales Growth shows a positive trend, but the TTM Compounded Profit Growth is negative. The OPM % has also fluctuated, indicating volatility in operational efficiency.

The compounded sales growth for the last 3 years is 19%, showcasing the strong revenue expansion of the company. However, the TTM sales growth is only 1% , indicating a slowdown. The compounded profit growth for the last 3 years is 84%, showcasing the strong profit expansion of the company, however, the TTM profit growth is -2%, indicating a decline. The OPM% shows fluctuation between 2014 to 2025. Overall, the company shows strong sales growth but profit growth is inconsistent.

The company demonstrates good capital efficiency and returns. The ROCE and ROE are healthy, indicating effective use of capital and shareholder funds. However, there's a slight decrease in ROCE in the most recent year.

Return on Capital Employed (ROCE) has generally improved over the years, peaking at 32% in March 2024 but declining to 28% in March 2025. This demonstrates the company's ability to generate profit from its capital employed, though the recent decrease warrants attention. Return on Equity (ROE) exhibits a similar trend, peaking at 32% in March 2024 and then declining to 28% in March 2025. This indicates how effectively the company is using shareholders' investments to generate profits. Overall, the metrics show strong capital efficiency and returns.

Nucleus Software exhibits strong financial health and prudence. The company has minimal debt and a consistent dividend payout, indicating responsible financial management.

The debt-to-equity ratio remained very low, close to 0 between 2014 and 2025, this indicates that the company has been very conservative in its use of debt, relying more on equity to finance its operations. The dividend payout % from 2014 to 2025 indicates a commitment to sharing profits with shareholders, although the payout ratio has varied over the years. Overall, the company exhibits strong financial health and prudence.

The shareholding and ownership structure of Nucleus Software is a significant strength. A consistently high promoter holding indicates strong confidence in the company's prospects. Increasing or stable FII and DII holdings suggest growing institutional interest and confidence in the company's performance and governance.

The promoter holding has been consistently high, around 73%, indicating a strong alignment of management and shareholder interests. FII holding has increased from 2.85% in Mar 2022 to 4.83% in Mar 2025, suggesting increased confidence from foreign investors. Similarly, DII holding has increased from 0.00% in Mar 2022 to 1.50% in Mar 2025, indicating growing domestic institutional interest. Overall, the shareholding and ownership structure of Nucleus Software is a significant strength.

The Operating Profit Margin (OPM) % has exhibited fluctuations over the quarters, indicating some volatility in operational efficiency.

The OPM % quarterly fluctuates which indicates that Nucleus Software must proactively manage its diverse segments to ensure consistent overall financial health.

Foreign exchange exposure can be inferred from the company's operations. The company's interest income and expense figures suggest minimal direct interest rate risk.

The other income shows fluctuation between 2014 to 2025 which indicates that the company is exposed to foreign exchange risk

Other Liabilities show fluctuations which indicates that the company needs to manage the liabilities effectively.

The other liabilities from 2014 to 2025 shows that the company has some contingent liability which needs to be managed effectively